NovoCure Limited
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $575.5M | $1.05B | $234.7M |
| FY2021 | $729.0M | $1.14B | $208.8M |
| FY2022 | $750.5M | $1.19B | $115.3M |
| FY2023 | $783.6M | $1.15B | $240.8M |
| FY2024 | $880.6M | $1.24B | $163.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $575.5M | $1.05B | $234.7M |
| FY2021 | $729.0M | $1.14B | $208.8M |
| FY2022 | $750.5M | $1.19B | $115.3M |
| FY2023 | $783.6M | $1.15B | $240.8M |
| FY2024 | $880.6M | $1.24B | $163.8M |